1. Accomplishments in 2008 in the management of curable metastatic colorectal cancer;Adam;Gastrointest. Cancer Res.,2009
2. The BRAF mutation is associated with the prognosis in colorectal cancer;Ahn;J. Cancer Res. Clin. Oncol.,2014
3. Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: pooled analysis of the CRYSTAL and OPUS randomised clinical trials;Bokemeyer;Eur. J. Cancer,2012
4. FOLFOX4 plus cetuximab treatment and RAS mutations in colorectal cancer;Bokemeyer;Eur. J. Cancer,2015
5. EGFR genomic alterations in cancer: prognostic and predictive values;Bronte;Front. Biosci. (Elite Ed.),2011